DiagnosTear Technologies Inc. (CSE:DTR)

Market Cap	23.17M -21.2%
Revenue	n/a
Net Income	n/a
EPS	n/a
Shares Out	60.19M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	500
Average Volume	4,137
Open	0.3850
Previous Close	0.3900
Day's Range	0.3850 - 0.3850
52-Week Range	0.2000 - 0.8800
Beta	n/a
RSI	41.06
Earnings Date	n/a

About DiagnosTear Technologies

DiagnosTear Technologies Inc., an ophthalmic company, engages in developing and commercializing disruptive diagnostic solutions for eye diseases. It develops TeaRx Dry Eye, a CE-IVD approved test based on the TeaRx platform intended for the identification and monitoring of Dry Eye Syndrome (TeaR DES); TeaRx Red Eye for differential assessment of adenoviral conjunctivitis, herpetic keratitis, and allergic conjunctivitis; and TeaRx Tear Collector, a proprietary microfluidic tear collector that allows non-invasive collection of 1 microliter of tea...

• Industry: Ophthalmic Goods
• Founded: 2023
• Country: Canada
• Stock Exchange: Canadian Securities Exchange
• Ticker Symbol: DTR